BioCentury
ARTICLE | Financial News

Ventrus Biosciences amends IPO

November 22, 2010 8:00 AM UTC

Ventrus Biosciences Inc., New York, N.Y. Business: Gastrointestinal, Genitourinary Date announced: 11/16/10 Type: IPO To be raised: Up to $22.5 million Shares: 2.8 million Price: $6-$7 Underwriters: R...